Literature DB >> 6035772

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

B Johansson, B E Roos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6035772     DOI: 10.1016/0024-3205(67)90193-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  19 in total

1.  Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.

Authors:  S Engelborghs; B Marescau; P P De Deyn
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

Review 2.  Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.

Authors:  T Nakajima
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

Review 3.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 4.  Dopamine and disease.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1970-10-17       Impact factor: 8.262

5.  Treatment of Parkinsonism with laevodopa.

Authors:  S F Murphy
Journal:  Ir J Med Sci       Date:  1971-03       Impact factor: 1.568

6.  5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.

Authors:  B Johansson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

7.  Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease.

Authors:  W J Weiner; H L Klawans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

8.  Monoamines in the brain cerebrospinal fluid of facial pain patients.

Authors:  A J Bouckoms; W H Sweet; C Poletti; P Lavori; D Carr; W Matson; P Gamache; N Aronin
Journal:  Anesth Prog       Date:  1992

9.  Cerebrospinal fluid choline in extrapyramidal disorders.

Authors:  S M Aquilonius; B Nyström; J Schuberth; A Sundwall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-10       Impact factor: 10.154

10.  Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

Authors:  J J Mann; M Stanley; R D Kaplan; J Sweeney; A Neophytides
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.